ATARA BIOTHERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value of $85.25 million as of 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue · last filed 2018-05-08
- 2018-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $85.25M.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $7.43M.
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $4.10M.
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value $1.39M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value |
|---|---|
| 2018-03-31 | $85.25M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $7.43M 10-K · filed 2018-02-27 |
| 2017-09-30 | $4.10M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.39M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $6.52M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.37M 10-K · filed 2017-03-09 |
| 2016-09-30 | $6.28M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $7.12M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $3.90M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $12.98M 10-K · filed 2016-03-04 |
| 2015-09-30 | $15.26M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $44.74M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $28.87M 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |